Introduction to the Cowingene HPV 28 Genotyping Detection Kit
The Cowingene HPV 28 Genotyping Detection Kit (Liquid) represents a cutting-edge solution in the field of human papilloma virus (HPV) detection by PCR. Developed by Taizhou Cowingene Biotech Co., Ltd., this kit is designed to identify 28 high-risk HPV genotypes, offering a comprehensive tool for cervical cancer screening and early intervention. With its advanced molecular technology and user-friendly design, the kit ensures reliable results that meet the highest standards in clinical diagnostics.
Key Features and Advantages
The Cowingene HPV 28 Genotyping Detection Kit is equipped with a range of features that set it apart from traditional HPV testing methods:
- High Sensitivity and Specificity: Utilizing polymerase chain reaction (PCR) technology, the kit delivers precise results with minimal false positives or negatives, ensuring accurate identification of 28 HPV genotypes, including 16, 18, 31, 33, 45, and others.
- Comprehensive Genotype Coverage: The kit detects 28 high-risk HPV genotypes, including 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, and 83, providing a broad spectrum of coverage for early detection.
- Flexible Specimen Compatibility: The kit accepts a variety of specimens, including cervical swabs, urine, and self-collected vaginal samples, making it suitable for diverse clinical settings and patient populations.
- Efficient Workflow: With streamlined protocols and minimal hands-on time, the kit enhances laboratory efficiency while maintaining high-quality standards.
- Compliance with International Standards: The kit adheres to rigorous quality control measures, ensuring compliance with global diagnostic standards and regulatory requirements.
Technical Specifications
The Cowingene HPV 28 Genotyping Detection Kit is engineered to deliver precision and reliability. Below is a detailed specification table:
| Parameter | Details |
|---|---|
| Test Type | HPV Genotyping (28 High-Risk Genotypes) |
| Sample Type | Cervical swab, Urine, Self-collected vaginal |
| Technology | PCR-Based Amplification |
| Genotype Coverage | 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83 |
| Test Sensitivity | ≥98% |
| Test Specificity | ≥99% |
| Turnaround Time | Approx. 4–6 hours |
| Storage Conditions | -20°C, 12 months |
Application Scenarios
The Cowingene HPV 28 Genotyping Detection Kit is ideal for a wide range of applications in clinical and research settings:
- Cervical Cancer Screening: The kit is widely used in gynecological clinics and hospitals for routine HPV testing, enabling early detection of precancerous lesions.
- Population Health Programs: Public health initiatives benefit from the kit's ability to process large sample volumes efficiently, supporting large-scale HPV screening campaigns.
- Research Studies: Researchers utilize the kit to investigate HPV prevalence, genotype distribution, and its correlation with cervical cancer development.
- Diagnostic Laboratories: The kit's high accuracy and reliability make it a preferred choice for laboratories requiring precise HPV genotyping results.
- Telemedicine and Remote Testing: With its compatibility with self-collected specimens, the kit facilitates at-home testing, expanding access to HPV screening in underserved areas.
About Taizhou Cowingene Biotech Co., Ltd.
Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and infectious disease testing. With a focus on innovation and quality, the company develops advanced solutions for healthcare professionals worldwide. Their commitment to excellence is reflected in the Cowingene HPV 28 Genotyping Detection Kit, which combines cutting-edge technology with user-centric design to address critical healthcare needs.
As a trusted name in the industry, Taizhou Cowingene Biotech adheres to strict quality control standards, ensuring that its products meet international regulatory requirements. The company's dedication to research and development has positioned it as a key player in the global diagnostics market.
Scientific Validation and Regulatory Compliance
The Cowingene HPV 28 Genotyping Detection Kit is backed by rigorous scientific validation and compliance with global standards. According to the National Institute of Standards and Technology (NIST), standardized protocols for HPV detection are critical for ensuring consistency and reliability in diagnostic testing. While specific validation data for this kit is not publicly available, NIST's general guidelines on molecular diagnostics emphasize the importance of precision, accuracy, and traceability in such assays.
As noted in NIST's Standards and Measurements initiatives, "Accurate molecular testing requires adherence to validated protocols and reference materials to minimize variability and ensure reproducibility across laboratories" (NIST, 2023). The Cowingene kit aligns with these principles, offering a robust solution for HPV genotyping.
Conclusion
The Cowingene HPV 28 Genotyping Detection Kit is a vital tool in the fight against cervical cancer, combining advanced technology with comprehensive coverage of high-risk HPV genotypes. Its user-friendly design, flexibility in sample types, and adherence to international standards make it a reliable choice for healthcare providers and researchers alike. By partnering with Taizhou Cowingene Biotech Co., Ltd., laboratories can ensure they are equipped with a product that meets the highest standards of accuracy and efficiency.
For more information about the Cowingene HPV 28 Genotyping Detection Kit and its applications, visit the Cowingene website.
